Boston Scientific Corp
(XTER:BSX)
€
86.5
-0.5 (-0.57%)
Market Cap: 126.52 Bil
Enterprise Value: 134.81 Bil
PE Ratio: 74.93
PB Ratio: 6.45
GF Score: 79/100 Boston Scientific Corp at Sanford C Bernstein Strategic Decisions Conference Transcript
May 31, 2023 / 12:00PM GMT
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
Great. Thanks, everybody, for joining. We're very excited to kick off this morning with Boston Scientific. We have CEO, Mike Mahoney. We're going to jump right in. Thanks so much for being here.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
Hi. Good morning.
Questions & Answers
Lee Michael Hambright
Sanford C. Bernstein & Co., LLC., Research Division - Analyst
So it's been a strong start for the year for med tech and Boston delivered an impressive 14% organic growth in the first quarter, which sets the company up for a really strong year. Maybe you can just kick us off with a few thoughts on the state of the business at Boston Scientific.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
Sure. Hello, everyone. Thanks for joining here, bright and early at 8 am. Really excited about really how we exited
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot